Innospec Inc.
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Innospec Inc., founded in 1938 as Octel Corp. and rebranded in January 2006, is a global company headquartered in Englewood, Colorado. It focuses on the creation, production, formulation, promotion, a...
Latest News
6 days ago · zacks.com
Innospec (IOSP) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseInnospec (IOSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
28 days ago · globenewswire.com
Innospec Schedules Third Quarter 2026 Earnings Release and Conference CallENGLEWOOD, Colo., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced that it will release third quarter 2026 earnings results on Tuesday, November 3, 2026 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Wednesday, November 4, 2026, at 9:00 a.m. ET.
2 months ago · zacks.com
Innospec (IOSP) Up 2% Since Last Earnings Report: Can It Continue?Innospec (IOSP) reported earnings 30 days ago. What's next for the stock?
3 months ago · seekingalpha.com
Innospec: Topline Is Growing As ExpectedWith the oilfield segment leading topline growth, even more growth should be expected as the adoption of DRA expands and the firm re-enters the Mexico market. In Q2 of 2026, revenue grew 12%, beating estimates by $34.17 million. The firm is now in a better financial position to command a higher sales multiple. The Performance chemical segment still experiences volume declines, raising concerns about the firm over investing by adding 10% capacity in a weak market.
3 months ago · zacks.com
IOSP's Q2 Earnings Surpass Estimates on Broad-Based GrowthInnospec's Q2 earnings beat estimates as all three businesses delivered revenue growth, while a debt-free balance sheet supports further investment.
3 months ago · zacks.com
Is Innospec (IOSP) Stock Outpacing Its Basic Materials Peers This Year?Here is how Innospec (IOSP) and Ingevity (NGVT) have performed compared to their sector so far this year.
3 months ago · seekingalpha.com
Innospec Inc. (IOSP) Q2 2026 Earnings Call TranscriptInnospec Inc. (IOSP) Q2 2026 Earnings Call Transcript
3 months ago · marketbeat.com
Innospec Q2 Earnings Call HighlightsInnospec NASDAQ: IOSP reported higher second-quarter revenue and net income as all three operating segments posted double-digit sales growth and operating-income gains, while the company continued repair and optimization work at its North Carolina Performance Chemicals facilities.
3 months ago · zacks.com
Innospec (IOSP) Tops Q2 Earnings and Revenue EstimatesInnospec (IOSP) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $1.26 per share a year ago.
3 months ago · globenewswire.com
Innospec Reports Second Quarter 2026 Financial ResultsStrong contributions from all businesses with revenues up 12 percent and operating income up 16 percent
Add to Watchlist
Select watchlists to add or remove IOSP